2022年，继续做好常态化疫情防控

China will continue its routine COVID-19 control measures this year, with a focus on rolling out targeted and scientific measures to minimize their impact on normal production and life, as well as accelerating research into vaccines and medicines, according to the Government Work Report released on Saturday.

根据3月5日发布的政府工作报告，2022年，中国将继续做好常态化疫情防控，落实科学精准防控措施，降低对正常生产生活的影响，并加快疫苗和特效药物研发。

The country will stick to its strategy of preventing imported infections and domestic flare-ups while refining its virus containment measures by stepping up the capabilities of port cities, intensifying studies into virus mutations and continuing the mass vaccination campaign.
中国将坚持外防输入、内防反弹，不断优化完善防控措施，加强口岸城市疫情防控，加大对病毒变异的研究，持续做好疫苗接种工作。

Last year, China consolidated outcomes achieved through its effective COVID-19 response and fully vaccinated over 85 percent of its population, according to the report, which Premier Li Keqiang delivered at the opening of the fifth session of the 13th National People's Congress.
根据李克强总理在十三届全国人大五次会议上作的政府工作报告，2021年，中国通过有效的防疫措施和85%的疫苗全程接种覆盖率巩固了所取得的抗疫成果。